The United States is rethinking its nuclear arsenal strategy, potentially reversing decades of effort to reduce its weapons count.
The European Parliament just wrapped up an enormous election. Several strident China critics secured seats for another term, and they’re vowing to build up a stronger Europe to counter Chinese aggression.
A top-selling Western weight-loss drug is taking the Chinese market by storm. But local Chinese rivals are eager to grab a slice, fueled by an early patent expiry on the drug’s active ingredient.
- U.S. Weighs More Nuclear Arms to Counter China, Russia
- U.S., S. Korea Coordinate Potential Nuclear Response
- China Hawks Reelected to EU Parliament
- EU to Unseal Tariffs Plan on Chinese Electric Cars
- Turkey Will Impose 40% Tariff on Chinese Vehicles
- China Creating Copycat Versions of Top-Selling Drugs
- Netherlands: Dutch Ship Harassed by Chinese Jets
- How Effective Will Biden’s Border Order Be?
- SHEIN, Temu Orders Could Face Delays Amid Curbs
- Fast Fashion Giant SHEIN Under Scrutiny in Europe
- Parade Shines Light on Falun Dafa in Prague